Story perspectives

George Church's Anti-Aging Paper Retracted Amid Data Issues

8/14/2025

26 6

Summary

Story summary

Renowned geneticist George Church faces a setback as his groundbreaking paper on anti-aging gene therapy is retracted due to data inconsistencies found during an internal review at Rutgers University. Coauthors, including BioViva CEO Elizabeth Parrish, argue that this decision jeopardizes the future of longevity research. Despite acknowledging the data issues, Church insists the core findings remain valid, marking a rare blemish in his impressive publishing record.

1 of 1

Story summary

Renowned geneticist George Church faces a setback as his groundbreaking paper on anti-aging gene therapy is retracted due to data inconsistencies found during an internal review at Rutgers University. Coauthors, including BioViva CEO Elizabeth Parrish, argue that this decision jeopardizes the future of longevity research. Despite acknowledging the data issues, Church insists the core findings remain valid, marking a rare blemish in his impressive publishing record.